shot-button
Banner Banner
Home > Brand Media News > Indian Scientist Abhijeet Satani Invited to Assist DBS Surgery in London

Indian Scientist Abhijeet Satani Invited to Assist DBS Surgery in London

Updated on: 27 May,2023 07:58 PM IST  |  Mumbai
BrandMedia | brandmedia@mid-day.com

Abhijeet Satani is a highly acclaimed scientist and researcher who has gained international recognition for his groundbreaking contributions in the fields of neuroscience, radiology, prosthetics, phantom limbs, and general anatomy.

Indian Scientist Abhijeet Satani Invited to Assist DBS Surgery in London

In a momentous development, esteemed Indian scientist Abhijeet Satani has received a prestigious invitation from a renowned surgeon team and the Medical Council of the United Kingdom to assist in a groundbreaking surgery in London. The procedure, known as deep brain stimulation, will be performed on a patient suffering from cocaine addiction. Notably, Abhijeet's patent technology, the 'Brain-Computer Interface Module,' will be utilized during the surgery, highlighting his innovative contributions to the field of medical science.


Abhijeet Satani is a highly acclaimed scientist and researcher who has gained international recognition for his groundbreaking contributions in the fields of neuroscience, radiology, prosthetics, phantom limbs, and general anatomy. He is widely known for his remarkable invention of the Brain-Computer Interface and alternative nervous system. Through his extensive research, Abhijeet has focused on unraveling the complexities of the human brain, understanding brain development, analyzing the impact of external interactions on the brain, and using technology to bridge gaps in human inefficiencies. His pioneering work has resulted in numerous intellectual properties, including patents, and has been cited by esteemed scientists and researchers in the field.


Deep brain stimulation (DBS) is a surgical technique that involves implanting a brain pacemaker, a medical device that delivers electrical impulses to targeted areas of the brain. This procedure has shown great promise in treating various neurological disorders, including Parkinson's disease, epilepsy, and obsessive-compulsive disorder. Now, the surgical team in London aims to leverage DBS to address addiction.


Abhijeet Satani, an exceptional scientist from India, has been at the forefront of medical innovation with his groundbreaking research and development in the field of neurology. His invention, the 'Brain-Computer Interface Module,' has garnered international acclaim for its ability to provide real-time feedback to surgeons, offering live signals of a patient's brain activity during surgical procedures. This revolutionary invention eliminates the need for repetitive procedures, thereby saving both patients and doctors precious time and resources. Abhijeet's remarkable contribution has earned him a patent.

The invitation extended to Abhijeet Satani to assist in the London surgery is not only a moment of immense pride for India but also a testament to the country's significant contributions to global healthcare. The medical community in India has long been revered for its expertise and innovative solutions, and Abhijeet's involvement in this landmark surgery further solidifies India's position as a leader in cutting-edge medical advancements.

The application of deep brain stimulation to address addiction represents a significant shift in the approach to tackling substance abuse disorders. By targeting specific brain regions associated with addiction, this surgery offers hope for individuals who have battled substance dependency for extended periods.

Moreover, Abhijeet's patent technology has the potential to revolutionize the health systems and policies worldwide. The medical community eagerly awaits the outcome of the London surgery, as its success could pave the way for a paradigm shift in addiction treatment methodologies.

Dr. Collins, the head of the surgical team, expressed her enthusiasm and confidence in Abhijeet's expertise. "Abhijeet Satani's contributions to the field of neurology have been truly remarkable. We are honored to have him join us for this surgery and utilize his patent technology. This collaboration has the potential to change the lives of countless individuals battling addiction," said Dr. Collins.

The highly anticipated surgery is scheduled to take place next month at a renowned London hospital. Medical experts from around the world will closely monitor the procedure. The outcome of this groundbreaking surgery could not only provide new hope for addicts but also prompt a reevaluation of addiction treatment strategies on a global scale.

As Abhijeet Satani prepares to embark on this historic journey, the world eagerly anticipates the results of the surgery and the potential implications it may have on addiction treatment and healthcare policies. With his expertise and innovative technology, Abhijeet's involvement in this London surgery serves as a shining example of the power of collaboration and the transformative impact of scientific advancements on society.

India stands proud as one of its exceptional scientists takes center stage in an international medical breakthrough. Abhijeet Satani's achievement not only reinforces India's reputation as a hub of exceptional talent but also showcases the country's commitment to advancing healthcare for the betterment of humanity. This milestone serves as a reminder that scientific innovations know no boundaries and have the potential to revolutionise the health systems and policies worldwide.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK